Prot# IM103008: Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosuppression Trial (BENEFIT)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/2/069/24/10

Funding

  • ICON Clinical Research, LLC (IM103008/BENEFIT)
  • Bristol-Myers Squibb Company (IM103008/BENEFIT)